How AI will reshape pharma by 2025
Drug Target Review
DECEMBER 20, 2024
These digital twins allow pharmaceutical companies to design clinical trials with fewer participants, while still providing reliable evidence to assess a drugs effectiveness. Smith states, weve definitely come across people in the pharma industry who worry that AI means companies might steal our data or use it in harmful ways.
Let's personalize your content